Bangladesh vs Botswana: HIV-positive TB patients on ART (antiretroviral therapy)
Bangladesh
93.0%
in 2024
Botswana
93.0%
in 2024
Bangladesh rank
85th
Botswana rank
85th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bangladesh
- Botswana
How they compare
Bangladesh currently reports 93.0% against 93.0% in Botswana, a difference of 0.0%.
The two have swapped places 7 times across 16 shared years of data; in 2008 it was Bangladesh ahead.
Bangladesh ranks 85th and Botswana ranks 85th of 144 countries.
Across the 3 decades both report, Bangladesh averaged higher in 2 and Botswana in 1.
Head to head by decade
| Decade | Bangladesh | Botswana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 79.5% | 34.0% | 45.5% | Bangladesh |
| 2010s | 95.3% | 76.1% | 19.2% | Bangladesh |
| 2020s | 91.5% | 92.8% | 1.2% | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bangladesh or Botswana?
- Bangladesh, at 93.0% against 93.0% in Botswana as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bangladesh and Botswana?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Botswana?
- 16 years are reported by both, from 2008 to 2024.
- How do Bangladesh and Botswana rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bangladesh ranks 85th and Botswana ranks 85th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.